What is the ROCE (Return on Capital Employed) of OptiNose this year?
The ROCE of OptiNose is 0.26 undefined this year.
OptiNose ROCE 2024
OptiNose ROCE
0.26
Ticker
OPTN
ISIN
US68404V1008
WKN
A2H5PR
In 2024, OptiNose's return on capital employed (ROCE) was 0.26, a -73.41% increase from the 0.99 ROCE in the previous year.
OptiNose Aktienanalyse
What does OptiNose do?
OptiNose Inc is a leading company in the field of nasal therapy, focused on improving the quality of life for patients with various upper respiratory tract conditions. The company was founded in 2010 and is headquartered in Yardley, Pennsylvania, USA. OptiNose developed a new therapy approach for nasal diseases based on the technology of the "Exhalation platform." This technology utilizes the patient's natural exhaling to deliver medication deep into the nasal and sinus regions where it is most needed. OptiNose Inc has patented and further developed this technology in 2009. The company's business model is based on the development and marketing of medications and medical devices that utilize the Exhalation platform technology. This innovative technology can be used to treat various upper respiratory conditions and complaints, including chronic sinusitis, allergic rhinitis, migraines, and other headache disorders. OptiNose Inc currently operates in two main business areas: therapeutic products and diagnostic and monitoring devices. Therapeutic products include various medications delivered through the Exhalation platform technology, as well as accessories such as spray devices. The diagnostic and monitoring devices include various products aimed at testing different diseases affecting the upper respiratory tract. One of OptiNose Inc's most well-known products is the XHANCE nebulizer, used to deliver inhaled medications deep into patient's nasal passages. Other important products include the OPTIMIST system, used for medication delivery to treat sinus and nasal conditions, and the Sinuva sinus implant, used for the treatment of nasal cavity narrowing and polyps. In addition, OptiNose Inc works closely with various research and development partners to develop new diagnostic and therapeutic approaches for upper respiratory tract diseases. In this way, the company is always seeking new opportunities to improve the quality of life for patients with these conditions. OptiNose Inc is a dynamic and innovative company focused on the development and marketing of advanced nasal therapy solutions. With modern technology, highly qualified personnel, and a strong focus on the needs of its patients, it will certainly continue to achieve significant success in the future. OptiNose ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling OptiNose's Return on Capital Employed (ROCE)
OptiNose's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing OptiNose's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
OptiNose's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in OptiNose’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about OptiNose stock
How has the ROCE (Return on Capital Employed) of OptiNose developed compared to the previous year?
The ROCE of OptiNose has increased by -73.41% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of OptiNose?
A high Return on Capital Employed (ROCE) indicates that OptiNose has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of OptiNose?
A low ROCE (Return on Capital Employed) can indicate that OptiNose has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from OptiNose impact the company?
An increase in the ROCE of OptiNose can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of OptiNose affect the company?
A decrease in ROCE of OptiNose can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of OptiNose?
Some factors that can affect OptiNose's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of OptiNose so important for investors?
The ROCE of OptiNose is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can OptiNose take to improve the ROCE?
To improve the ROCE, OptiNose can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does OptiNose pay?
Over the past 12 months, OptiNose paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OptiNose is expected to pay a dividend of 0 USD.
What is the dividend yield of OptiNose?
The current dividend yield of OptiNose is .
When does OptiNose pay dividends?
OptiNose pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of OptiNose?
OptiNose paid dividends every year for the past 0 years.
What is the dividend of OptiNose?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is OptiNose located?
OptiNose is assigned to the 'Health' sector.
Wann musste ich die Aktien von OptiNose kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of OptiNose from 11/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.
When did OptiNose pay the last dividend?
The last dividend was paid out on 11/17/2024.
What was the dividend of OptiNose in the year 2023?
In the year 2023, OptiNose distributed 0 USD as dividends.
In which currency does OptiNose pay out the dividend?
The dividends of OptiNose are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von OptiNose
Our stock analysis for OptiNose Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OptiNose Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
